"Glycoprotein involvement in cardiac fibrobiast-myocyte communication "
"Glycoprotein involvement in cardiac fibrobiast-myocyte communication "
批准号:
8376451
负责人:
Jennifer E Van Eyk
金额:
$31.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Acute myocardial infarctionAmino AcidsAngioplastyApoptosisArchitectureBiological MarkersBlood CirculationBlood flowCardiacCardiac MyocytesCardiovascular DiseasesCell CommunicationCell DeathCell surfaceCellsCessation of lifeCicatrixClinicalCoculture TechniquesCommunicationComplementComplexCoronary arteryDetectionDevelopmentDiagnosisEnsureEnvironmentExtracellular MatrixFarGoFibroblastsGlycoconjugatesGlycoproteinsGoldHeartHeart failureHydrogen PeroxideHypoxiaImmunohistochemistryInfarctionInjuryInstructionIschemiaKnowledgeLabelLeadLinkMass Spectrum AnalysisMethodsMonitorMuscleMuscle CellsMyocardialMyocardial InfarctionMyocardial IschemiaMyocardiumMyofibroblastNecrosisOligosaccharidesOxidative StressPatientsPeptidesPhenotypePlayPolysaccharidesPredispositionPrincipal InvestigatorProteinsProteomeProteomicsReactionRegulationRelative (related person)Reperfusion TherapyRiskRoleSamplingSerumSignal TransductionSiteSliceSpecificityStressTechnologyTherapeutic InterventionTissuesTranslatingTroponinValidationVentricular RemodelingWound Healingautocrinebasecell typeclinical Diagnosisclinically relevantglycosylationin vivoinjuredinnovationmultiple reaction monitoringnovelparacrineresponseresponse to injury
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The blockage of coronary arteries can result in a heart attack (acute myocardial infarction; Ml) and
permanent loss of cardiac muscle tissue. The resulting destruction of the complex cardiac architecture,
formation of scar tissue, and myocardial remodeling increases risk of death. The heart's initial response to
injury is synchronous and involves, in part, the reciprocal interaction between cardiac fibroblasts and
myocytes, the two primary cell types comprising the heart. Recent findings suggest that soluble proteins
secreted from cardiac fibroblasts and myocytes, also called the secretome, can modulate the infarct
microenvironment (extracellular matrix, ECM). It is the cell surface that not only acts as a physical barrier
but senses of the local ECM microenvironment that initiates the intrinsic cellular protective mechanisms upon
injury. Thus, the cell-environment interface is the main site of this interplay. We hypothesize that
fibroblasts are the linchpin and their respond to injury launches wound healing while also promoting myocyte
survival. Fibroblasts accomplish this by altering the ECM microenvironment surrounding myocytes,
especially those present in the infarct border zone. Many of the proteins comprising cell-environment
interface are glycosylated. In this proposal, we will use a number of innovative methods to target, enrich,
quantify (relative and absolute) and characterize the glycoproteome of the cell-environment interface of
myocytes and fibroblasts alone and in co-culture with and without injury induced by H2O2. This includes using
a novel twist when co-culturing, in which the proteins from one cell type have a covalent quantitative labeled
which provides a mass spectrometry friendly marker to distinguishing the cell origin of each protein. We
hypothesize that cell-specific glycoproteome comprising the cell-environment interface is responsible to the
intrinsic susceptibility to H2O2 of myocytes compared to fibroblasts (SA 1). Furthermore, that a subset of the
fibroblast-specific secreted proteins which are elevated in co-culture induces myocyte-protection and this
protective phenotype is enhanced by the action of when fibroblast, themselves are injured (SA-2). Finally,
we hypothesize that glycoproteins present in the microenvironment which are exclusively elevated in
response of H2O2 will be detected in the circulation of patients with myocardial injury (ischemia) prior to the
elevation of cardiac troponins (gold standard markers for Ml). In summary, the protein complement of the
cell-environment interface has not been fully elucidated for either cardiac fibroblasts or myocytes. This
knowledge is fundamental to developing clinical approaches to protect the heart and potentially provide
robust clinical biomarkers
RELEVANCE (See instructions);
This is the first systematic analysis of the glycoproteins which comprise the secretome and cell surface of
myocytes and fibroblast, two major cell types of the heart, for which their interaction is synergetic and can
results in myocyte protection. These protective glycoproteins could be targets suitable for therapeutic
intervention. As well, the myocardial and cardiac fibroblast specific hypoxic stimulated secreted proteins
from cardiac fibroblasts and myocytes that circulating and are elevated in patients with myocardial ischemia
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORALE-SeroNet Immune Bioanalytics Core
-
批准号:10688398
-
项目类别:
-
资助金额:$25.5万
-
财政年份:2020
-
负责人:Jennifer E Van Eyk
-
依托单位:
CORALE-SeroNet Immune Bioanalytics Core
-
批准号:10222435
-
项目类别:
-
资助金额:$85.33万
-
财政年份:2020
-
负责人:Jennifer E Van Eyk
-
依托单位:
A new post-translational modification, citrullination, changes in heart failure
-
批准号:8256288
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2012
-
负责人:Jennifer E Van Eyk
-
依托单位:
A new post-translational modification, citrullination, changes in heart failure
-
批准号:8431700
-
项目类别:
-
资助金额:$19.28万
-
财政年份:2012
-
负责人:Jennifer E Van Eyk
-
依托单位:
"Glycoprotein involvement in cardiac fibrobiast-myocyte communication "
-
批准号:8183670
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2011
-
负责人:Jennifer E Van Eyk
-
依托单位:
TAS::75 0872::TAS THE JOHNS HOPKINS PROTEOMIC INNOVATION CENTER IN HEART FAILURE
-
批准号:8320842
-
项目类别:
-
资助金额:$217.23万
-
财政年份:2010
-
负责人:Jennifer E Van Eyk
-
依托单位:
CRT and Mitochondrial Function and Proteome Post-Translational Modifications
-
批准号:8011127
-
项目类别:
-
资助金额:$45.57万
-
财政年份:2010
-
负责人:Jennifer E Van Eyk
-
依托单位:
TAS::75 0872::TAS THE JOHNS HOPKINS PROTEOMIC INNOVATION CENTER IN HEART FAILURE
-
批准号:8537322
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2010
-
负责人:Jennifer E Van Eyk
-
依托单位:
AB Sciex Q-Trap 5500 LC/MS/MS
-
批准号:7793254
-
项目类别:
-
资助金额:$49.87万
-
财政年份:2010
-
负责人:Jennifer E Van Eyk
-
依托单位:
TAS::75 0872::TAS THE JOHNS HOPKINS PROTEOMIC INNOVATION CENTER IN HEART FAILURE
-
批准号:8175610
-
项目类别:
-
资助金额:$214.52万
-
财政年份:2010
-
负责人:Jennifer E Van Eyk
-
依托单位:
TAS::75 0872::TAS THE JOHNS HOPKINS PROTEOMIC INNOVATION CENTER IN HEART FAILURE
-
批准号:8895194
-
项目类别:
-
资助金额:$245.55万
-
财政年份:2010
-
负责人:Jennifer E Van Eyk
-
依托单位:
TAS::75 0872::TAS THE JOHNS HOPKINS PROTEOMIC INNOVATION CENTER IN HEART FAILURE
-
批准号:8727408
-
项目类别:
-
资助金额:$204.81万
-
财政年份:2010
-
负责人:Jennifer E Van Eyk
-
依托单位:
Genomics and Proteomic Core
-
批准号:8011130
-
项目类别:
-
资助金额:$41.78万
-
财政年份:2010
-
负责人:Jennifer E Van Eyk
-
依托单位:
Post-translational regulation of embryonic stem cells: a proteomic study.
-
批准号:7462818
-
项目类别:
-
资助金额:$40.73万
-
财政年份:2009
-
负责人:Jennifer E Van Eyk
-
依托单位:
Post-translational regulation of embryonic stem cells: a proteomic study.
-
批准号:7860449
-
项目类别:
-
资助金额:$40.3万
-
财政年份:2009
-
负责人:Jennifer E Van Eyk
-
依托单位:
CORE--PROTEOMICS
-
批准号:7394297
-
项目类别:
-
资助金额:$57.42万
-
财政年份:2007
-
负责人:Jennifer E Van Eyk
-
依托单位:
MITOCHONDRIAL FUNCTION IN ISCHEMIC HEART DISEASE
-
批准号:7114064
-
项目类别:
-
资助金额:$36.56万
-
财政年份:2005
-
负责人:Jennifer E Van Eyk
-
依托单位:
MOLECULAR POLARIZATION IN DYSSYNCHRONOUS HEARTS AND CRT
-
批准号:6951260
-
项目类别:
-
资助金额:$25.93万
-
财政年份:2004
-
负责人:Jennifer E Van Eyk
-
依托单位:
MOLECULAR POLARIZATION IN DYSSYNCHRONOUS HEARTS AND CRT
-
批准号:7118575
-
项目类别:
-
资助金额:$25.9万
-
财政年份:--
-
负责人:Jennifer E Van Eyk
-
依托单位:
CRT and Mitochondrial Function and Proteome Post-Translational Modifications
-
批准号:8545889
-
项目类别:
-
资助金额:$41.53万
-
财政年份:--
-
负责人:Jennifer E Van Eyk
-
依托单位:
海外基金